Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study

Claude Négrier, Johnny Mahlangu, Michaela Lehle, Pratima Chowdary, Olivier Catalani, Ronald J. Bernardi, Víctor Jiménez‐Yuste, Benjamin M. Beckermann, Christophe Schmitt, Giuliana Ventriglia, Jerzy Windyga, Roseline d’Oiron, Paul Moorehead, Sunita Koparkar, Vanda Teodoro, Amy D. Shapiro, Johannes Oldenburg, Cédric Hermans